David CoryAdamsonMD

PubMed

• Emerging and investigational targeted chemotherapy and immunotherapy agents for metastatic brain tumors.
  J. Tanner McMahon, Razan Faraj, David Cory Adamson> ;Expert Opinion on Investigational Drugs. 2020 Oct 26
• 4 citations
  DNX-2401: an investigational drug for the treatment of recurrent glioblastoma.
  Brandon D. Philbrick, David Cory Adamson> ;Expert Opinion on Investigational Drugs. 2019 Nov 22
• The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential.
  Casey L. Anthony, Nikol Mladkova-Suchy, David Cory Adamson> ;Expert Opinion on Investigational Drugs. 2019 Aug 20
• Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma.
  Philbrick, B. D.,Adamson, D. C.> ;Expert Opin Investig Drugs. 2019 Jan 25
• AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.
  Chunhui Di, Nikol Mladkova, James Lin, Brian E. Fee, Miriam V. Rivas, Kang Chunsheng, Darell D. Bigner, David Cory Adamson> ;International Journal of Oncology. 2017 Nov 1
• Management of Glioblastoma Multiforme in Elderly Patients: A Review of the Literature.
  Sameer H. Halani, Ranjith Babu, D. Cory Adamson> ;World Neurosurgery. 2017 Sep 1
• Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas.
  Sameer H. Halani, D. Cory Adamson> ;OncoTargets and Therapy. 2016 Sep 12
• OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.
  Jing Li, Chunhui Di, Jenny Jing, Qun Di, Jonathan Nakhla, David Cory Adamson> ;International Journal of Oncology. 2015 Nov 1
• Novel chemotherapeutics and other therapies for treating high-grade glioma.
  Kang, J. H., Adamson, C.> ;Expert opinion on investigational drugs. 2015 Aug 21
• Editorial: Turning fluorescence into black and white
  Peter E. Fecci, Ranjith Babu, D. Cory Adamson, John H. Sampson> ;Journal of Neurosurgery. 2015 Apr 3
• 6 citations
  Radiation-induced malignant gliomas: a current review.
  Aladine A. Elsamadicy, Ranjith Babu, John P. Kirkpatrick, David Cory Adamson> ;World Neurosurgery. 2015 Apr 1
• Adherens junctional associated protein-1: A novel 1p36 tumor suppressor candidate in gliomas (Review)
  Liang Zeng, Brian E. Fee, Miriam Rivas, James Lin, David Cory Adamson> ;International Journal of Oncology. 2014 Jul 1
• 1 citations
  AJAP1 is Dysregulated at an Early Stage of Gliomagenesis and Suppresses Invasion Through Cytoskeleton Reorganization
  Lei Han, Kailiang Zhang, Junxia Zhang, Liang Zeng, Chunhui Di, Brian E. Fee, Miriam Rivas, Zhaoshi Bao, Tao Jiang, Darrell D. Bigner, Chunsheng Kang, David Cory Adamson> ;CNS Neuroscience & Therapeutics. 2014 May 1
• 1 citations
  The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.
  Zeng, L., Kang, C., Di, C., Fee, B. E., Rivas, M. V., Lin, J., Adamson, D. C.> ;International journal of oncology. 2014 Feb 1
• Editorial: emerging treatment strategies for malignant gliomas.
  Adamson, D. C.> ;Curr Drug Discov Technol. 2012 Dec
• Stopping cancer in its tracks: using small molecular inhibitors to target glioblastoma migrating cells.
  Austin K. Mattox, Jing Li, David Cory Adamson> ;Current Drug Discovery Technologies. 2012 Nov 30
• 1 citations
  Targeted radiotherapy for malignant gliomas.
  Daniel S. Oh, David Cory Adamson, John P. Kirkpatrick> ;Current Drug Discovery Technologies. 2012 Nov 30
• Fluorescence-Guided Malignant Glioma Resections
  Ranjith Babu, David Cory Adamson> ;Current Drug Discovery Technologies. 2012 Nov 30
• Emerging Treatment Strategies for Malignant Gliomas.
  David Cory Adamson> ;Current Drug Discovery Technologies. 2012 Sep 28
• Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma
  Ranjith Babu, D. Cory Adamson> ;Core Evidence. 2012 Sep 14
• Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
  Mattox, A. K., Lark, A. L., Adamson, D. C.> ;Clin Neurol Neurosurg. 2012 May
• Deletion or Epigenetic Silencing of AJAP1 on 1p36 in Glioblastoma
  Ningjing Lin, Chunhui Di, Kathy Bortoff, Jinrong Fu, Peter Truszkowski, Patrick J. Killela, Christopher G. Duncan, Roger E. McLendon, Darell D. Bigner, Simon G. Gregor...> ;Molecular Cancer Research. 2012 Jan 12
• Conquering Mount Fuji: Resolution of Tension Pneumocephalus with a Foley Urinary Catheter
  Shahid M. Nimjee, Ali R. Zomorodi, D. Cory Adamson> ;Case reports in radiology. 2011 Jul 2
• 11 citations
  Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism.
  Turner, D. A., Adamson, D. C.> ;Journal of neuropathology and experimental neurology. 2011 Feb 5
• The future role of personalized medicine in the treatment of glioblastoma multiforme
  Jing Li, Chunhui Di, Austin K. Mattox, Linda Wu, D. Cory Adamson> ;Pharmacogenomics and Personalized Medicine. 2010 Aug 19
• Join now to see all